At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Restylane and Restylane-Ldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind Study Comparing Safety and Tolerability of Restylane® With and Without Addition of 0.3% Lidocaine HCL During Correction of Nasolabial Folds
In Brief
A clinical study evaluating Restylane and Restylane-L for Nasolabial Folds. Completed, enrolled 60 participants across 3 sites.
Detailed Summary
Safety \& tolerability study that compares Restylane to Restylane with Lidocaine (Restylane-L) while correcting wrinkles in the area around your nose.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Folds
CountriesUnited States
CollaboratorsQ-Med Scandinavia, Inc.
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedNov 2008
Primary CompletionJan 2009
Study CompletionMar 2009
TodayJul 2026
First PostedNov 25, 2008
Enrollment StartNov 1, 2008
Primary CompletionJan 1, 2009
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.6 years ago
Interventions
Restylane and Restylane-Ldevice
This is a split face design and each subject received both Restylane and Restylane-L. Treatments were double blind, randomized, and successive.